Defining and targeting mechanisms of eosinophilic inflammation in a new era of severe asthma treatment
Journal of Clinical Investigation · 17.06.2024 · 134 (12)
DOI: 10.1172/jci182410 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 17.06.2024. Verfasst von Joshua A Boyce und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Asthma, Eosinophils, Eosinophilia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Allergy and Immunology, Department of Medicine, and.
- Center for Human Immunobiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Zitieren
APA
Boyce, J. A., & Eisenbarth, S. C. (2024). Defining and targeting mechanisms of eosinophilic inflammation in a new era of severe asthma treatment. Journal of Clinical Investigation, 134(12). https://doi.org/10.1172/jci182410
Vancouver
Boyce JA, Eisenbarth SC. Defining and targeting mechanisms of eosinophilic inflammation in a new era of severe asthma treatment. Journal of Clinical Investigation. 2024;134(12). doi:10.1172/jci182410
BibTeX
@article{Boyce2024,
author = {Boyce, Joshua A and Eisenbarth, Stephanie C},
title = {Defining and targeting mechanisms of eosinophilic inflammation in a new era of severe asthma treatment},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {12},
doi = {10.1172/jci182410}
}
EUVIMED